Differential Diagnosis

Medical / Technology / Education feed

The future of biopharma

Shifts in how diseases are diagnosed and prevented, custom treatments, curative therapies, digital therapeutics, and precision intervention could upend current business models in biopharma.

Deloitte's Five forces to 2040

Prevention and early detection
Customized treatments - interventions for very small populations
Curative therapies - gene therapy
Digital therapeutics - complementing or replacing medications
Precision intervention - robotics, nanotechnology, or tissue engineering reducing medications


Source: www2.deloitte.com